| [1] |
Cheng Mingrong, Dai Dejian.
Efficacy of Zhenqi Fuzheng Capsule combined with ursodeoxycholic acid on primary biliary cholangitis and its impact on thyroid function
[J]. Clinical Focus, 2020, 35(3): 260-263.
|
| [2] |
Wang Yankun1， Ma Junji2, Zhang Ming2.
Role of cytokeratin 7 in pathological diagnosis of liver cirrhosis
[J]. Clinical Focus, 2019, 34(2): 124-127.
|
| [3] |
Huang Guangming, Gu Dahui, Hao Yaqin, He Zhijun.
Effect of nutritional status on clinical outcomes in elderly patients with hepatic cirrhosis
[J]. Clinical Focus, 2019, 34(2): 128-131.
|
| [4] |
Jin Yan, Ge Zhihua, Sun Yuanyuan, Xu Shuyan, Shao Jianguo.
Clinical study of AIMS65 score for risk assessment of esophagealgastric variceal bleeding in liver cirrhosis
[J]. Clinical Focus, 2018, 33(6): 498-501.
|
| [5] |
Zhao Wen， Zhang Siyu， Lu Yu， Zhao Suxian， Wang Rongqi， Nan Yuemin.
FibroTouch combined with FIB-4， APRI and GPRI in diagnosis of liver fibrosis
[J]. Clinical Focus, 2018, 33(2): 140-144.
|
| [6] |
Yin Kaige, Jin Xiaoxu, Feng Zhijie.
Endoscopic treatment of esophagogastric varices in cirrhosis
[J]. Clinical Focus, 2018, 33(11): 929-932.
|
| [7] |
Cheng Ran, Xu Xiaoyuan.
Diagnosis and therapy of ascites in liver cirrhosis
[J]. Clinical Focus, 2018, 33(11): 921-924.
|
| [8] |
Xu Manman1, Cheng Kailiang2, Qiu Qian3, Zhao Xinyu2, Duan Zhongping1, Wang Li2, Chen Yu1.
Factors associated with adherence to antiviral therapy in patients with HBV-related cirrhosis
[J]. Clinical Focus, 2018, 33(11): 950-955.
|
| [9] |
Kong Ming， Shi Hongbo， Bai Li， Yao Jia， Chen Yu， Duan Zhongping.
Characteristics of plasma amino acids in patients with HBVrelated chronic hepatitis， cirrhosis and acute on chronic liver failure
[J]. Clinical Focus, 2016, 31(7): 732-735,740.
|
| [10] |
Wei Xinliang， Wei Sichen， Tian Shuying， Kong Yu， Wang Weiwei， Jiang Hongyu.
Correlation analysis and clinical significance of serum omentin and adiponectin in patients with liver cirrhosis
[J]. Clinical Focus, 2016, 31(12): 1313-1317.
|
| [11] |
Zhao Zhengbin1a，Fan Wenhai1b， Chen Qingfeng2，Yao Liqiong1a.
Analysis of pathogen distribution and drug resistance in liver cirrhosis patient with spontaneous bacterial peritonitis
[J]. Clinical Focus, 2016, 31(11): 1222-1224,1228.
|
| [12] |
Wang Qingli;Yang Lin;Liu Qi.
Clinical observation on effect of coffeic acid on leukocyte anal platelet count in patients with cirrhosis
[J]. Clinical Focus, 2015, 30(9): 1027-1.0281e+007.
|
| [13] |
Ge Xiuzhen;Wang Yuming;Zheng Zhongqing;Wang Tao;Wang Bangmao.
Risk factors in poor prognosis after endoscopic variceal ligation and endoscopic injection sclerotherapy of esophageal varices caused by liver cirrhosis
[J]. Clinical Focus, 2015, 30(3): 250-252256.
|
| [14] |
LIU Ya;WU Jin-ming;CHEN Mei-qin.
Efficacy of entecavir for 96 weeks in patients with hepatitis B virus-related cirrhosis and chronic hepatitis B
[J]. Clinical Focus, 2014, 29(6): 672-675.
|
| [15] |
LI Yong-mei;YAN Guo-bao.
Serum tumor markers,whole abdominal CT and peritoneal exfoliated cells in diagnosis of ascites
[J]. Clinical Focus, 2014, 29(5): 521-523524.
|
